ABSTRACT
Pharmacotherapies shown to reduce risk of death, stroke, recurrent coronary ischemia following Acute Myocardial Infarction are often not titrated to the recommended dose following discharge.
Pharmacotherapies shown to reduce risk of death, stroke, recurrent coronary ischemia following Acute Myocardial Infarction are often not titrated to the recommended dose following discharge.